FDA approves world’s most expensive drug worth $3.5 Million a Dose for Hemophilia.
The food and drug administration has approved a $3.5 million medicine for hemophilia. Thus making it the world’s most expensive medicine. The CSL Behring’s hemophilia B gene therapy can free patients from regular treatments. As a matter of fact, a single dose of the medicine would cost a fortune which is $3.5 million.
According to a study, the CSL Behring’s Hemgenix can reduce bleeding events over the course of the year by 54 percent if administered once. The medicine will substitute 94 percent of the patients from time-consuming and costly infusions of Factor IX, which is currently used to control the potentially deadly condition, a report in Bloomberg said.
Biotechnology investor, and chief executive officer of Loncar Investments, Brad Loncar, said
“While the price is a little higher than expected, I do think it has a chance of being successful because 1) existing drugs are also very expensive and 2) hemophilia patients constantly live in fear of bleeds”. “A gene therapy product will be appealing to some,”-Brad Loncar added.
According to the FDA(food and drug administration)-Hemophilia B affects about 1 in 40,000 people and accounts for roughly 15% of those with the disease
